US Patent 7323467 3-heteroaryl-3,5-dihydro-4-oxo-4
Patent 7323467 was granted and assigned to Sanofi on January, 2008 by the United States Patent and Trademark Office.
All edits
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+102 characters)
Article
Patent abstract
The invention discloses and claims therapeutic uses of compounds of general formula (I)
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07323467 3-heteroaryl-3,5-dihydro-4-oxo-4 US Patent 7323467 3-heteroaryl-3,5-dihydro-4-oxo-4
Infobox
Patent Number
0732346700
Patent Number
732346700
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 30 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
073234670
Date of Patent
January 29, 2008
0Patent Application Number
117493420
Date Filed
May 16, 2007
0Official Website
Patent Primary Examiner
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
073234670
Date of Patent
January 29, 2008
0Patent Application Number
117493420
Date Filed
May 16, 2007
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 23 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07323467 3-heteroaryl-3,5-dihydro-4-oxo-4
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07323467
Date of patent
January 29, 2008
Patent application number
11749342
Date Filed
May 16, 2007
Patent primary examiner
Find more entities like US Patent 7323467 3-heteroaryl-3,5-dihydro-4-oxo-4
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.